Atwood & Palmer’s CVS Health CVS Stock Holding History

Atwood & Palmer’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.3K	Hold	535	–	–	﹤0.01%	243
2026 Q1	$38.4K	Hold	535	–	–	﹤0.01%	262
2025 Q4	$42.5K	Hold	535	–	–	﹤0.01%	248
2025 Q3	$40.3K	Sell	535 -285	-35%	-$19.5K	﹤0.01%	259
2025 Q2	$56.6K	Hold	820	–	–	﹤0.01%	230
2025 Q1	$55.6K	Buy	820 +570	+228%	+$34.1K	﹤0.01%	218
2024 Q4	$11.2K	Sell	250 -5,000	-95%	-$281K	﹤0.01%	332
2024 Q3	$330K	Hold	5,250	–	–	0.02%	125
2024 Q2	$310K	Hold	5,250	–	–	0.02%	125
2024 Q1	$419K	Hold	5,250	–	–	0.03%	114
2023 Q4	$415K	Hold	5,250	–	–	0.03%	116
2023 Q3	$367K	Hold	5,250	–	–	0.03%	114
2023 Q2	$363K	Hold	5,250	–	–	0.03%	123
2023 Q1	$390K	Hold	5,250	–	–	0.04%	104
2022 Q4	$489K	Hold	5,250	–	–	0.04%	111
2022 Q3	$501K	Hold	5,250	–	–	0.05%	107
2022 Q2	$486K	Sell	5,250 -44	-0.8%	-$4.29K	0.05%	103
2022 Q1	$536K	Sell	5,294 -270	-5%	-$28.4K	0.05%	106
2021 Q4	$574K	Hold	5,564	–	–	0.05%	106
2021 Q3	$472K	Buy	5,564 +270	+5%	+$22.6K	0.04%	111
2021 Q2	$442K	Sell	5,294 -577	-10%	-$47.3K	0.04%	116
2021 Q1	$442K	Buy	5,871 +551	+10%	+$40.1K	0.04%	112
2020 Q4	$363K	Buy	5,320 +320	+6%	+$20.8K	0.04%	118
2020 Q3	$292K	Sell	5,000 -185	-4%	-$11.5K	0.04%	111
2020 Q2	$337K	Hold	5,185	–	–	0.05%	99
2020 Q1	$308K	Buy	5,185 +185	+4%	+$12.3K	0.05%	99
2019 Q4	$371K	Hold	5,000	–	–	0.05%	97
2019 Q3	$315K	Hold	5,000	–	–	0.04%	101
2019 Q2	$272K	Hold	5,000	–	–	0.04%	110
2019 Q1	$270K	Hold	5,000	–	–	0.04%	107
2018 Q4	$328K	Sell	5,000 -166	-3%	-$12.4K	0.05%	93
2018 Q3	$407K	Sell	5,166 -543	-10%	-$38.8K	0.05%	92
2018 Q2	$367K	Sell	5,709 -191,583	-97%	-$12.6M	0.05%	94
2018 Q1	$12.3M	Sell	197,292 -2,219	-1%	-$159K	1.75%	19
2017 Q4	$14.5M	Sell	199,511 -680	-0.3%	-$49.4K	2.03%	20
2017 Q3	$16.3M	Sell	200,191 -2,169	-1%	-$172K	2.36%	19
2017 Q2	$16.3M	Buy	202,360 +7,774	+4%	+$614K	2.55%	18
2017 Q1	$15.3M	Sell	194,586 -3,034	-2%	-$242K	2.44%	20
2016 Q4	$15.6M	Sell	197,620 -2,944	-1%	-$238K	2.81%	15
2016 Q3	$17.8M	Sell	200,564 -1,563	-0.8%	-$148K	3.24%	9
2016 Q2	$19.4M	Buy	202,127 +3,059	+2%	+$305K	3.5%	7
2016 Q1	$20.6M	Buy	199,068 +59,963	+43%	+$5.83M	3.67%	5
2015 Q4	$13.6M	Buy	139,105 +7,163	+5%	+$702K	2.58%	13
2015 Q3	$12.7M	Sell	131,942 -2,772	-2%	-$291K	2.49%	11
2015 Q2	$14.1M	Sell	134,714 -1,347	-1%	-$138K	2.54%	11
2015 Q1	$14M	Sell	136,061 -4,573	-3%	-$463K	2.51%	11
2014 Q4	$13.5M	Sell	140,634 -3,872	-3%	-$341K	2.53%	10
2014 Q3	$11.3M	Buy	144,506 +37,740	+35%	+$2.98M	2.13%	16
2014 Q2	$8.05M	Sell	106,766 -35,192	-25%	-$2.66M	2.15%	14
2014 Q1	$10.6M	Buy	141,958 +2,422	+2%	+$171K	2.49%	15
2013 Q4	$9.99M	Buy	139,536 +11,864	+9%	+$762K	2.46%	17
2013 Q3	$7.25M	Buy	127,672 +842	+0.7%	+$50.2K	2%	23
2013 Q2	$7.25M	Buy	+126,830	New	+$7.35M	1.96%	22

Other funds holding CVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Atwood & Palmer's CVS Position: Q2 2026 in Review

Atwood & Palmer held its CVS Health (CVS) position steady in Q2 2026 at 535 shares worth $55.3K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Atwood & Palmer first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.6M in Q1 2016. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Atwood & Palmer held 535 shares of CVS Health worth $55.3K as of Q2 2026.
Atwood & Palmer left its CVS Health share count unchanged in Q2 2026.
CVS Health made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #243 holding.
Atwood & Palmer first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
Atwood & Palmer's CVS Health position peaked at $20.6M in Q1 2016.
650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.